Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients

BACKGROUND: The global push for the use of hydroxychloroquine (HCQ) and chloroquine (CQ) against COVID-19 has resulted in an ongoing discussion about the effectivity and toxicity of these drugs. Recent studies report no effect of (H)CQ on 28-day mortality. We investigated the effect of HCQ and CQ in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lammers, A.J.J., Brohet, R.M., Theunissen, R.E.P., Koster, C., Rood, R., Verhagen, D.W.M., Brinkman, K., Hassing, R.J., Dofferhoff, A., el Moussaoui, R., Hermanides, G., Ellerbroek, J., Bokhizzou, N., Visser, H., van den Berge, M., Bax, H., Postma, D.F., Groeneveld, P.H.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524430/
https://www.ncbi.nlm.nih.gov/pubmed/33007454
http://dx.doi.org/10.1016/j.ijid.2020.09.1460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524430/
https://www.ncbi.nlm.nih.gov/pubmed/33007454
http://dx.doi.org/10.1016/j.ijid.2020.09.1460

Ejemplares similares